• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

283
63
47
46
28

COUNTRY

26
12
11
10
10

PRICE

309
495
992
1,317

PUBLISHED

84
119
325
1,317

PRODUCT TYPE

1,147
86
51
17
16

Infectious Diseases

Antibiotics, antifungals, antivirals and other infectious disease pharmaceuticals account for a multibillion sector. The battle against contagious diseases takes places in a highly changeable environment, with a wealth of commercial opportunities arising from quickly emerging threats (e.g. avian flu) and the infectious disease and vaccination policies of national governments and international healthcare organisations. Keep track of the latest industry news and activity with the publications listed under Research and Markets’ Infectious Diseases category.

Our reports, books, and subscriptions will allow you to explore licensing, patents, forecasts, market trends, clinical trials, and drug pipelines. Leading players featured in our publications include Pfizer, Roche, Novartis, AstraZeneca, Sanofi, Johnson & Johnson, Merck, Abbott, GlaxoSmithKline, Lilly, and more.

For publications about Infectious Disease Testing please visit the relevant category under Healthcare and Medical Devices. Show Less
Read more

PRODUCT TITLE

Chikungunya - Pipeline Review, H2 2014

Chikungunya - Pipeline Review, H2 2014 Summary This, ‘Chikungunya - Pipeline Review, H2 2014’, provides an overview of the Chikungunya’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM

HIV-1 Infection - Pipeline Review, H2 2014

HIV-1 Infection - Pipeline Review, H2 2014 Summary This, ‘HIV-1 Infection - Pipeline Review, H2 2014’, provides an overview of the HIV-1 Infection’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Hand, Foot And Mouth Disease - Pipeline Review, H2 2014

Hand, Foot And Mouth Disease - Pipeline Review, H2 2014 Summary This, ‘Hand, Foot And Mouth Disease - Pipeline Review, H2 2014’, provides an overview of the Hand, Foot And Mouth Disease’s therapeutic...

October 2014
FROM

Toxoplasmosis - Pipeline Review, H2 2014

Toxoplasmosis - Pipeline Review, H2 2014 Summary This, ‘Toxoplasmosis - Pipeline Review, H2 2014’, provides an overview of the Toxoplasmosis’s therapeutic pipeline. This report provides comprehensive...

October 2014
FROM

Gonorrhea - Pipeline Review, H2 2014

Gonorrhea - Pipeline Review, H2 2014 Summary This, ‘Gonorrhea - Pipeline Review, H2 2014’, provides an overview of the Gonorrhea’s therapeutic pipeline. This report provides comprehensive information...

October 2014
FROM
Competitor Analysis: Ebola Virus Vaccines and Therapeutics Competitor Analysis: Ebola Virus Vaccines and Therapeutics - Product Thumbnail Image

Competitor Analysis: Ebola Virus Vaccines and Therapeutics

The present Competitive Intelligence Report about prophylaxis and therapy of Ebola virus infections provides a competitor evaluation in the field of new molecules for prevention or treatment of Ebola...

October 2014
FROM
Competitor Analysis: Anti-Infective Peptides Competitor Analysis: Anti-Infective Peptides - Product Thumbnail Image

Competitor Analysis: Anti-Infective Peptides

The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor evaluation in the field of R&D projects with anti-infective...

October 2014
FROM
Disease & Therapy Review (DTR) Executive Market Summaries Disease & Therapy Review (DTR) Executive Market Summaries - Product Thumbnail Image

Disease & Therapy Review (DTR) Executive Market Summaries

Disease & Therapy Review is meant to be an accurate and efficient executive synopsis of the indications that IPD users look up most frequently Each report includes epidemiology from the IPD (Incidence...

November 2014

Candidiasis - Pipeline Review, H2 2014

Candidiasis - Pipeline Review, H2 2014 Summary This, ‘Candidiasis - Pipeline Review, H2 2014’, provides an overview of the Candidiasis’s therapeutic pipeline. This report provides comprehensive information...

September 2014
FROM

Human Papillomavirus Infections - Pipeline Review, H2 2014

Human Papillomavirus Infections - Pipeline Review, H2 2014 Summary This, ‘Human Papillomavirus Infections - Pipeline Review, H2 2014’, provides an overview of the Human Papillomavirus Infections’s...

September 2014
FROM

Influenza A Infections - Pipeline Review, H2 2014

Influenza A Infections - Pipeline Review, H2 2014 Summary This, ‘Influenza A Infections - Pipeline Review, H2 2014’, provides an overview of the Influenza A Infections’s therapeutic pipeline. This...

September 2014
FROM

H3N2 Infection - Pipeline Review, H2 2014

H3N2 Infection - Pipeline Review, H2 2014 Summary This, ‘H3N2 Infection - Pipeline Review, H2 2014’, provides an overview of the H3N2 Infection’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM

Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2014

Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2014 Summary This, ‘Leishmaniasis (Kala-Azar) - Pipeline Review, H2 2014’, provides an overview of the Leishmaniasis (Kala-Azar)’s therapeutic pipeline. This...

September 2014
FROM

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014 Summary This, ‘Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014’, provides...

September 2014
FROM

Herpes Simplex Infections - Pipeline Review, H2 2014

Herpes Simplex Infections - Pipeline Review, H2 2014 Summary This, ‘Herpes Simplex Infections - Pipeline Review, H2 2014’, provides an overview of the Herpes Simplex Infections’s therapeutic pipeline. This...

September 2014
FROM

H1N1 Infection - Pipeline Review, H2 2014

H1N1 Infection - Pipeline Review, H2 2014 Summary This, ‘H1N1 Infection - Pipeline Review, H2 2014’, provides an overview of the H1N1 Infection’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM

Dengue - Pipeline Review, H2 2014

Dengue - Pipeline Review, H2 2014 Summary This, ‘Dengue - Pipeline Review, H2 2014’, provides an overview of the Dengue’s therapeutic pipeline. This report provides comprehensive information on the...

September 2014
FROM

Ebola Viral Infections - Pipeline Review, H2 2014

Ebola Viral Infections - Pipeline Review, H2 2014 Summary This, ‘Ebola Viral Infections - Pipeline Review, H2 2014’, provides an overview of the Ebola Viral Infections’s therapeutic pipeline. This...

September 2014
FROM

Pulmonary Tuberculosis - Pipeline Review, H2 2014

Pulmonary Tuberculosis - Pipeline Review, H2 2014 Summary This, ‘Pulmonary Tuberculosis - Pipeline Review, H2 2014’, provides an overview of the Pulmonary Tuberculosis’s therapeutic pipeline. This...

September 2014
FROM

Genital Herpes - Pipeline Review, H2 2014

Genital Herpes - Pipeline Review, H2 2014 Summary This, ‘Genital Herpes - Pipeline Review, H2 2014’, provides an overview of the Genital Herpes’s therapeutic pipeline. This report provides comprehensive...

September 2014
FROM
Loading Indicator

Our Clients

Our clients' logos